Business Description
Fresenius Medical Care AG
NAICS : 621492
SIC : 8092
ISIN : DE0005785802
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.84 | |||||
Debt-to-EBITDA | 4.23 | |||||
Interest Coverage | 3.57 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 1.17 | |||||
Beneish M-Score | -2.55 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3 | |||||
3-Year EBITDA Growth Rate | -8 | |||||
3-Year EPS without NRI Growth Rate | -17.1 | |||||
3-Year FCF Growth Rate | -15.1 | |||||
3-Year Book Growth Rate | 6.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 21.13 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 2.45 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 63.67 | |||||
9-Day RSI | 64.78 | |||||
14-Day RSI | 62.65 | |||||
6-1 Month Momentum % | -1.83 | |||||
12-1 Month Momentum % | -18.7 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.46 | |||||
Quick Ratio | 1.09 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 56.71 | |||||
Days Sales Outstanding | 71.71 | |||||
Days Payable | 20.99 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.18 | |||||
Dividend Payout Ratio | 0.66 | |||||
3-Year Dividend Growth Rate | -2.3 | |||||
Forward Dividend Yield % | 3.18 | |||||
5-Year Yield-on-Cost % | 3.58 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 13.42 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 25.33 | |||||
Operating Margin % | 7.95 | |||||
Net Margin % | 2.73 | |||||
FCF Margin % | 7.79 | |||||
ROE % | 3.84 | |||||
ROA % | 1.53 | |||||
ROIC % | 3.41 | |||||
3-Year ROIIC % | -33.37 | |||||
ROC (Joel Greenblatt) % | 15.69 | |||||
ROCE % | 5.34 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 20.67 | |||||
Forward PE Ratio | 11.02 | |||||
PE Ratio without NRI | 20.67 | |||||
Shiller PE Ratio | 8.94 | |||||
Price-to-Owner-Earnings | 7.67 | |||||
PS Ratio | 0.57 | |||||
PB Ratio | 0.79 | |||||
Price-to-Free-Cash-Flow | 7.26 | |||||
Price-to-Operating-Cash-Flow | 5.36 | |||||
EV-to-EBIT | 14.34 | |||||
EV-to-Forward-EBIT | 10.34 | |||||
EV-to-EBITDA | 7.8 | |||||
EV-to-Forward-EBITDA | 6.7 | |||||
EV-to-Revenue | 1.11 | |||||
EV-to-Forward-Revenue | 1.06 | |||||
EV-to-FCF | 14.32 | |||||
Price-to-Projected-FCF | 0.39 | |||||
Price-to-Median-PS-Value | 0.46 | |||||
Earnings Yield (Greenblatt) % | 6.97 | |||||
FCF Yield % | 13.77 | |||||
Forward Rate of Return (Yacktman) % | 11.5 |